mobiquity_technoliges_logo.jpg
Mobiquity Technologies Expands Partnership with AWINR Brands, Adding Twelve New Clients to its Digital Marketing Platform
March 04, 2024 08:30 ET | Mobiquity Technologies, Inc.
NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (OTC: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies, Inc. Partners with AWINR Brands as Digital Marketing Platform Provider
February 14, 2024 08:30 ET | Mobiquity Technologies, Inc.; AWINR Brands
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (OTC: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions, is...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
December 01, 2023 09:00 ET | Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Best Order Flow Analytics
BigShort.com Wins Best Order Flow Analytics at Benzinga Fintech Awards
November 20, 2023 12:53 ET | BigShort
NEW YORK, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BigShort.com was recently named to the Benzinga Global Fintech Listmakers and recognized as the platform with the Best Order Flow Analytics. The awards,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD at Psych Congress 2023
September 05, 2023 08:00 ET | Cingulate Inc.
KANSAS CITY, Kan., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies' ElecTech Platform: Changing the Landscape of Political Campaign Engagement
August 23, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (Nasdaq: MOBQ), a leading provider of next-generation data intelligence and advertising technology solutions, announces its...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies and Optical Near ME Rollout Joint Marketing Program to Eye Care Industry with Next-Generation Marketing Solutions
August 01, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Signs Strategic Alliances to Bring Additional Demand to Its 1st Party Ad Serving Platform for Publishers
July 26, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
mobiquity_technoliges_logo.jpg
Mobiquity Technologies Announces Strategic Partnership with Optical Near ME to Integrate Advertising into AI-Driven, Immersive Optometry Marketing and Communications
July 18, 2023 08:00 ET | Mobiquity Technologies, Inc.
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technology solutions,...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
July 11, 2023 08:00 ET | Cingulate Inc.
KANSAS CITY, Kan., July 11, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...